Background: The ability of most biomarkers, such as N-terminal pro-B-type natriuretic peptide (NT-proBNP), to predict prognosis in heart failure can be affected by the state of renal function; therefore, there is the need for a biomarker that can predict prognosis accurately without the influence of renal function. The prognostic value of cysteine-rich protein 61 (CYR61/CCN1) in acute heart failure (AHF) patients has been proven.
Methods: A total of 248 patients hospitalized with AHF were recruited in this study, and serum CCN1 levels, NT-proBNP levels, and other necessary data of patients were collected upon admission. The correlation of serum CCN1 with estimated glomerular filtration rate (eGFR) was investigated, and the logistic regression model was used to investigate the prognostic value of serum CCN1 for 3-month mortality.
Results: Fifty-four of 248 patients died (21.8%) during a 3-month follow-up. Serum CCN1 had no significant correlation with eGFR (rho = -0.088, p = 0.167). In the overall population and patients without chronic kidney disease, results showed that both serum CCN1 and NT-proBNP were significantly associated with 3-month mortality. In patients with chronic kidney disease, serum CCN1 was significantly associated with 3-month mortality in logistic regression analysis (odds ratio = 2.40, p = 0.002) while NT-proBNP was not. Further in tertile group comparison, in patients with chronic kidney disease, higher tertile levels of serum CCN1 had a significantly higher risk of 3-month mortality compared to the lower tertile ones (odds ratio = 4.17, p = 0.013), but that of NT-proBNP did not.
Conclusion: Serum CCN1 level is not associated with eGFR, and it maintains the prognostic value in AHF patients with chronic kidney disease. CCN1 could be a potential novel prognostic biomarker in AHF patients with chronic kidney disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000501929 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[The Correlation of Serum and CCN1 Expression with Clinical Efficacy and Prognosis of Patients with Acute Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
December 2024
Department of Hematology, Nanjing Jiangning Hospital, Nanjing 211100, Jiangsu Province, China.
Objective: To determine the serum levels of mRNA and CCN1 in patients with acute leukemia (AL), and to analyze their relationship with the clinical efficacy and prognosis of the patients.
Methods: 103 AL patients admitted to our hospital from February 2015 to January 2019 were included as the study subjects. Additionally, 100 healthy subjects who underwent physical examinations during the same period were included as the control group.
CCN1-Mediated Signaling in Placental Villous Tissues after SARS-CoV-2 Infection in Term Pregnant Women: Implications for Dysregulated Angiogenesis.
Curr Issues Mol Biol
April 2024
Department of Gynecology and Obstetrics, University Hospital Essen, 45147 Essen, Germany.
The global spread of SARS-CoV-2 has increased infections among pregnant women. This study aimed to explore placental pathology alterations and angiogenic factor levels in term pregnant women after SARS-CoV-2 infection in a retrospective single-center study. Additionally, we investigated the role and underlying mechanism of the vascular inflammation-promoting, cysteine-rich protein 61 (CYR61/CCN1) in this context.
View Article and Find Full Text PDFSuppression of cerebral ischemia injury induced blood brain barrier breakdown by dexmedetomidine via promoting CCN1.
Aging (Albany NY)
February 2024
Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning, China.
Background: Blood-brain barrier (BBB) could aggravate cerebral ischemia injury. Dexmedetomidine (Dex) has been believed to play a protective role in cerebral ischemia injury-induced BBB injury.
Methods: Middle cerebral artery occlusion (MCAO) and oxygen-glucose deprivation (OGD) models were established to simulate cerebral ischemia injury.
Vitamin D analogue calcipotriol inhibits the profibrotic effects of transforming growth factor- β1 on pancreatic stellate cells.
Eur J Pharmacol
October 2023
Department of Hepatic Biliary Pancreatic Medicine, First Hospital of Jilin University, Changchun, China. Electronic address:
Objective: To evaluate the inhibitory effect of vitamin D analogue calcipotriol (Cal) on the fibrosis of pancreatic stellate cells (PSCs) induced by TGF-β1 and the rationality of Cal use in alcoholic chronic pancreatitis (ACP).
Material And Methods: Double-labeling immunofluorescence was used for the identification of VDRPSCs in the pancreas of healthy controls (HC) and ACP patients. Van Gieson staining for examination of collagen fibers.
Serum CYR61 as a potential biomarker to improve breast cancer diagnostics.
Biomark Med
October 2022
Department of Clinical Laboratory, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian 350001, China.
To investigate the role of serum CYR61 as a biomarker for the diagnosis of breast cancer and to analyze the association between serum CYR61 levels and the clinicopathological features in breast cancer patients. Serum CYR61 was measured in breast cancer patients and healthy controls by ELISA. The serum levels of CYR61 in breast cancer patients were higher than those in healthy controls.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!